Home / Generics
Generics
News
EMA recommends approval of abiraterone and thiotepa generics
posted 02/04/2021
In January and February 2021, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) hel... 
Teva and Sandoz launch new generics
posted 26/03/2021
In early 2021, Teva Pharmaceuticals announced the US launch of generic versions of NuvaRing® and AZOPT®. During the same peri... 
EMA recommends approval of fourth COVID-19 vaccine
posted 19/03/2021
11 March 2021 saw the European Medicines Agency (EMA) recommended granting a conditional marketing authorisation for the four...
Posaconazole, silodosin and droxidopa generics from Lupin and Sandoz
posted 12/03/2021
Early 2021 saw the launch of two generic versions of posaconazole in Canada and the US. In Canada, the first generic version... 
Biocon and Lupin launch generic tacrolimus capsules in US
posted 05/02/2021
India-based generics makers Biocon and Lupin have both launched generic tacrolimus capsules in the US. |
Research
Dispensing branded drugs costs Medicare over a billion dollars
posted 09/04/2021
Branded drugs dispensed instead of generics at the request of physicians and patients have incurred annual costs of over US$1... 
Technological approaches to drug repurposing for cancer treatment
posted 08/04/2021
Cancer is one of the leading causes of death in the world today, causing nearly 10 million deaths in 2018 alone. Despite exte... 
Debate about generic versus brand-name drugs for glaucoma
posted 24/03/2021
Glaucoma is a chronic, largely asymptomatic disease that often needs lifelong treatment. The choice of drugs is extremely imp... 
The role of authorized generics in improving access to medicines
posted 12/03/2021
In recent years, many authorized generic drug products have been launched by pharmaceutical companies at lower prices than th... 
Approving generics of polymer-based parenteral long-acting drugs
posted 12/03/2021
To assure the safety and the efficacy of drugs, quality and batch-to-batch reproducibility need to be guaranteed. In the case... |
General
US$1.2 FDA contract for generic drug computational tool
posted 16/04/2021
The US Food and Drug Administration (FDA) Office of Generic Drugs (ODG) has awarded a US$1.2 million contract to support the... 
Opportunities for generics with Korean patent expires in 2021
posted 12/03/2021
As part of ongoing action to improve the quality of generics and ensure an efficient and competitive generics market, the Kor... 
AIFA updates the Transparency Lists for generics
posted 26/02/2021
The Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) announced on 15 January 2021 the update of its Transparency... 
New generics company to offer low-cost versions of high-cost generics
posted 29/01/2021
Billionaire Marc Cuban has launched a new generics company – Marc Cuban Cost Plus – which ‘is dedicated to producing low-cost... 
Generics applications under review by EMA – January 2021
posted 22/01/2021
Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo... |
Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!
Generics
General
- US$1.2 FDA contract for generic drug computational tool
- Opportunities for generics with Korean patent expires in 2021
News
Research
Generics News Research General
- US$1.2 FDA contract for generic drug computatio...Generics/General | Posted 16/04/2021
- Dispensing branded drugs costs Medicare over a...Generics/Research | Posted 09/04/2021
- Technological approaches to drug repurposing fo...Generics/Research | Posted 02/04/2021
- EMA recommends approval of abiraterone and thio...Generics/News | Posted 02/04/2021
Biosimilars News Research General
- Characteristics associated with biosimilar use...Biosimilars/Research | Posted 16/04/2021
- British Columbia adds adalimumab to biosimilar...Biosimilars/General | Posted 16/04/2021
- Biosimilars in the treatment of psoriasisBiosimilars/Research | Posted 16/04/2021
- Advances for Formycon and Alteogen’s eye diseas...Biosimilars/News | Posted 16/04/2021